Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CD86 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | CD79A | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
mRNA | RP11-6L6.2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | ZSCAN23 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
mRNA | RALGPS2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
mRNA | PAQR3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | ARHGEF17 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
mRNA | TSSC4 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
mRNA | HMBOX1 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
mRNA | WWTR1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |